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Magnetic retraction offers advantages over physical retraction by graspers because of reduced tissue trauma. The objectives of this
study are to investigate a novel method of magnetisation of bowel segments by intraluminal injection of magnetic glue and to
demonstrate the feasibility of magnetic retraction of bowel with sufficient force during minimal access surgery. Following an initial
materials characterisation study, selected microparticles of stainless steel (SS410-𝜇Ps) were mixed with chosen cyanoacrylate glue
(Loctite 4014). During intraluminal injection of the magnetic glue using ex vivo porcine colonic segments, a magnetic probe placed
at the injected site ensured that the SS410-𝜇Ps aggregated during glue polymerisation to form an intraluminal mucosally adherent
coagulum. The magnetised colonic segments were retracted by magnetic probes (5 and 10mm) placed external to the bowel wall.
A tensiometer was used to record the retraction force. With an injected volume of 2mL in a particle concentration of 1 g/mL, this
technique producedmaximalmagnetic retraction forces of 2.24± 0.23N and 5.11 ± 0.34N (𝑛 = 20), with use of 5 and 10mmprobes,
respectively. The results indicate that the formation of an intraluminal coagulum based on SS410-𝜇Ps and Loctite 4014 produces
sufficient magnetic retraction for bowel retraction.
1. Introduction
Retraction of bowel loops during minimal access surgery
(MAS) remains problematic because the low friction slippery
smooth andmoist surface resists grasping. For this reason, to
provide effective traction, the jaws of laparoscopic graspers
feature ridges or toothed profiles tominimize slip and for this
reason, the bowel is often grasped too tightly, increasing risk
of trauma and associated complications, for example, delayed
healing, adhesion formation, and even perforation [1]. The
potential bowel trauma during laparoscopic grasping is well
documented. One study [2] confirmed the low incidence
of successful grasping (62%) and highlighted the need for
improvements in laparoscopic grasping. This is particularly
pertinent to natural-orifice transluminal endoscopic surgery
(NOTES) and single port or port laparoscopic surgery
(SPLS).Thus exposure of the gallbladder [3] is difficult during
SPL cholecystectomy. Ryou and Thompson [4] described
the use of internal and external magnets for liver retraction
during experimental transcolonic (NOTES) cholecystectomy
and found that the magnetic system provided effective liver
retraction and significantly shortened the procedure time.
Magnetic interactions and magnetic force have attracted
considerable research for both medical and surgical appli-
cations [5, 6]. Magnetic microparticles and small magnets
have been used for MAS applications such as in magnetic
tissue retraction [4, 7, 8], magnetized islets separation for
transplantation [9], magnetic navigation of catheters [10] or
untethered devices (e.g., microrobots or magnetic capsules)
[11–13],magnetic detection andmarker [14–16], andmagnetic
compression anastomosis [17, 18]. Magnetic fields generated
by magnetic particles [14] or implanted magnets [16] have
been used for the detection of tumor or lesion sites. Clinically
the strong magnetic interaction between paired magnets
has been used to create a compression anastomosis for
revision of bilioenteric anastomotic stricture in a patient
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after live-related hepatic transplantation [17] and to create a
choledochojejunal anastomosis [18].
We have been investigating tissue magnetization by
magnetic nano/microparticles for MAS applications and
have previously reported two tissue ferromagnetisation
approaches for retraction: (i) surfacemagnetization by apply-
ing a small volume of glue-based magnetic media to the
mucosal surface [7] and (ii) by interstitial injection of
phosphate-buffered saline (PBS) ferrofluids [8]. In these
experiments injected ferromagnetisation was shown to be
superior to magnetisation by surface magnetic pellets as the
latter tended to peel off the tissue during retraction by
magnetic probes.
In the present study, we report a third novel approach
for the magnetization of bowel loops for magnetic retraction
during MAS and open surgery. This is based on intralu-
minal injection of glue-based magnetic glue which bonds
on polymerization to the mucosal layer of the bowel wall.
A magnetic probe is then inserted intraperitoneally and
placed on the serosal aspect to retract the magnetized bowel.
This paper reports the development and characterization of
cyanoacrylate magnetic glues containing dispersed stainless
steel microparticles.
2. Methods
2.1. Glues and Maximal Temperatures during Polymerisation.
Four medical grade glues were investigated for their suit-
ability in the formulation of injectable magnetic glues: Der-
mabond (Ethicon, Somerville, NJ, USA), Indermil (US Surgi-
cal, Norwalk, NJ, USA), and Histoacryl (Braun, Melsungen,
Germany) and Loctite 4014 (Henkel, Dusseldorf, Germany).
All are topical skin adhesives made of octyl-cyanoacrylate or
butyl-cyanoacrylate glues [19]. Since temperatures of 42∘C
and above are known to damage tissues [20], the extent of
maximal heat generation during glue polymerisation was
investigated. The heat sink effect resulting from perfusion
of the bowel wall was simulated by circulation of isotonic
solution by means of a pump on the serosal surface of
the colon segments which were placed in a water bath.
Figure 1 illustrates a thermal camera (Cedip Jade camera,
FLIR Systems, France) temperature measurement system in
an open bowel experimentwithin a humidity chamber. In this
initial study 0.5mL of glue was deposited onto the surface
of the bowel segment which was kept moist at 37∘C with
Hartmann’s solution circulating at 7 L/min to simulate in vivo
conditions including the heat sink of vascular perfusion.
2.2. Characterization of Magnetic Microparticles. Two types
of stainless steel microparticles (SS-𝜇Ps) were examined
in the initial materials characterisation: 410 microparticles
(SS410-𝜇Ps, Goodfellow Cambridge Ltd., Huntingdon, UK)
and 430 microparticles (SS430-𝜇Ps, from Alfa Aesar, A
JohnsonMatthey Company, Lancashire, UK). Both materials
had been previously reported in the literature [15, 21, 22] for
use inmedical/surgical applications.Themagnetic properties
of the two materials were quantified with a Superconduct-
ing Quantum Interference Device (SQUID) magnetometer
IR camera
Humidity chamberDepositing glue
Bowel
Water bath
Figure 1: Setup for study of heat generation during polymerisation
of the glues in an open bowel segment within a closed chamber.
(MPMS XL from Quantum Design, now part of Lot-Oriel
GmbH & Co. KG). The particle crystallinity was confirmed
by X-ray diffraction (XRD; STADI/P powder diffractometer
from Stoe) and their sizes were determined by scanning
electron microscopy (SEM; S-4800 from Hitachi). Chemical
composition of all particles was also analysed by inductively
coupled plasma optical emission spectrometry (ICP-OES;
Optima 5300 DV from Perkin Elmer).
2.3. Cyanoacrylate-Based Magnetic Glue. Loctite 4014 was
chosen to formulate the injectable cyanoacrylate-based mag-
netic glue in view of its lower cost ease of use (single com-
ponent) and its quick cure rate in high humidity conditions.
Due to its very low viscosity, a range of concentrations can
be mixed with magnetic particles for different applications.
Concentrations of particles ranging from 0.5 to 1 g/mL were
used for the magnetic bowel retraction studies. In the formu-
lation of high concentration magnetic glue (1 g/mL magnetic
fluid), 2.0 grams of SS410 magnetic particles was placed in a
Sure/Seal bottle and 2mL Loctite 4014 was added thereafter.
Themagnetic particles were thenmixed and suspended in the
liquid glue by vigorous hand shaking of the sealed bottle.
2.4. Magnetic Bowel Retraction. Figures 2(a) and 2(b) illus-
trates the components of the intraluminal retraction system
for MAS procedure: (i) specially designed intra-abdominal
injection probe was used with suction openings at its end to
facilitate intraluminal injection of magnetic glue media into
a bowel segment (Figure 2(a)); (ii) magnetic probe is held
on the serosal side adjacent to the site of injection to ensure
formation of a strongly magnetic coagulum, which adheres
to the mucosal surface on polymerisation (Figure 2(b)); (iii)
the magnetised bowel can then be retracted by the external
magnetic probe.
We used neodymium iron boron (NdFeB) disc mag-
nets with a remanence of 1.20 T (grade N35, Eclipse
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Figure 2: Magnetic retraction by intraluminal injection bowel magnetization. (a) Illustration of an intra-abdominal injection probe with
suction openings for capturing bowel wall to facilitate intraluminal injection. (b) Illustration of an intra-abdominal magnet probe with distal
magnet interacting with the injected magnetic glue attracted to the inner wall of the lumen by the abdominal magnet probe. (c) Photograph
of an ex vivo porcine bowel experimental setup for magnetic bowel retraction force measurement. (d) Illustration of a recorded retraction
force-distance curve for calculating peak force and work.
Magnetics Ltd., Sheffield, UK) of two diameters: 5mm and
10mm. Increasing the magnet’s axial length can increase its
magnetic field strength and attraction force to some degree,
but we found that a magnet with a length/diameter ratio of
2.0 is optimal, as no significant force increase is achieved
by longer magnets (data not shown). Additionally, a short
distalmagnet facilitates the design of both simple straight and
complex custom-designed probes.
The magnetic attraction force was measured using a
tensiometer (Model 5564, Intron Ltd., Buckinghamshire,
UK). Details on thismeasurement system have been reported
previously [7, 8]. Briefly, the ex vivo bowel segment is
fixed onto a support board with a free 15.0 cm segment
(Figure 2(c)) and placed in a water bath at 37∘C. After
injection magnetisation, a magnetic probe connected to the
tensiometer load cell was brought into contact with the bowel
for retraction force measurement. Figure 2(d) illustrates a
recorded retraction force-distance curve.
Several parameters can be derived from the recorded
retraction force and distance curve (Figure 2(d)). Peak force
[𝐹max (N)] represents the maximal attraction (or bonding)
force between themagnet and themagnetised tissue, and after
reaching 𝐹max, the probe starts to separate from the bowel
until it detaches completely from it. The stress [𝜎 (Pa)] at
peak force is derived from dividing 𝐹max by the probe end-
surface area. Work [𝑊 (J)] is defined as the area under the
force-distance curve, which represents the work required for
detachment of the two systems [23]. Work is calculated by
4 BioMed Research International
Table 1: Characteristics of the magnetic particles.
Size (diameter) 𝑀
𝑠
(emu/g) 𝐻
𝑐
(kOe) Fe/Cr (w%)
SS410-𝜇Ps Up to 50 𝜇mSEM 168.0 0.01 86.6 ± 6.8/12.6 ± 1.0
SS430-𝜇Ps Up to 40 𝜇mSEM 110.0 0.02 82.2 ± 6.7/16.9 ± 1.4
Magnetisation at saturation (𝑀
𝑠
) and coercivity (𝐻
𝑐
) measured with a SQUID magnetometer at 300K; iron and chromium percentage as deduced from ICP-
OES measurements and size as obtained by SEM characterizations.
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Figure 3: Averaged maximum temperatures were measured by the
IR thermal camera after 0.5mL of each glue was deposited onto
the surface of ex vivo porcine bowel (error bar: standard deviation,
number of test 𝑛 = 7).
a custom-written MATLAB (MathWorks, Cambridge, UK)
program using (1) which is based on linear trapezoidal rule
[24]:
𝑊 =
𝑁−1
∑
𝑖=0
(𝑥
𝑖+1
− 𝑥
𝑖
) ∗
(𝐹
𝑖
+ 𝐹
𝑖+1
)
2
, (1)
where W is adhesion work, 𝑥 is retraction distance, 𝐹 is
retraction force, 𝑖 is data sampling point, and 𝑁 is total
number of data points.
3. Results
3.1. Heat Generation by Glues. The maximal temperature
generated during glue polymerisation by the 4 medical grade
cyanoacrylate glues studied was obtained from the recorded
thermal camera image. Figure 3 plots the averaged maximal
temperaturesmeasured by the IR thermal camera after 0.5mL
of each glue was deposited onto the surface of ex vivo porcine
bowel (error bar: standard deviation, number of test 𝑛 = 7).
All showed safe heat generation (i.e., below 42∘C) except for
Histoacryl (maximal about 43.5∘C).
3.2. Characterisation of Magnetic Particles. Figures 4(a) and
4(b) present the appearance of stainless steel microparticles
as observed by electron microscopy and Figure 4(c) the
hysteresis curves at room temperature.
Results from XRD (not presented) and electron
microscopy findings showed both SS410 and SS430 particles
Table 2: Magnetic bowel retraction data.
𝐹max (N) 𝑊 (mJ) 𝜎 (kPa)
5mmmagnet probe 2.2 ± 0.2 34 ± 11 114 ± 11.7
10mmmagnet probe 5.1 ± 0.3 81 ± 17 65 ± 4.3
SS410-𝜇Ps-based magnetic glues at concentration 1 g/mL: intraluminally
injected volume of 2mL.
to be crystalline but polydispersed in size and shape with
particles’ diameters ranging from a few microns up to 50 𝜇m
(Figures 4(a) and 4(b)). Magnetic properties in terms of
magnetization as a function of applied magnetic field were
quantified at room temperature and the resulting curves are
shown in Figure 4(c). As expected the curves are symmetric
and the magnetization at saturation, 𝑀
𝑠
, is deduced from
the plateau, when the magnetization does not increase any
further with increasing magnetic field strength. SS410-𝜇Ps
(Figure 4(c1)) exhibit a higher magnetization at saturation
than SS430-𝜇Ps, and this is likely due to their slightly higher
iron content and a lower chromium doping (Table 1). The
coercivity refers to the magnetic field which needs to be
applied to reduce the magnetization of a material down to
zero after the magnetization of the sample has reached sat-
uration. For both SS-𝜇Ps the remanence (i.e., the remaining
magnetisation after the field has been removed) has been
found to be very small. These observations indicate that
both stainless steel 𝜇Ps even though too large to form stable
suspension would not present difficulty in dispersion in the
fluid due to magnetic interactions since the particles exhibit
no mutual magnetic attraction unless placed in a magnetic
field. SS410-𝜇Ps were chosen for the study in view of their
higher magnetization and lower coercivity (or remanence).
3.3. Measurement of Magnetic Bowel Retraction and Forces.
Harvested porcine colonic segments were used with injection
by a large gauge needle (16G or 1.7mm diameter × 50mm,
B. Braun Melsungen AG) to facilitate rapid injection of high
concentrationmagnetic glue, although a smaller gauge needle
(19G needle from BD Microlance 3, BD Drogheda, Ireland)
can also be used for slower injection. After withdrawal of the
needle, the small puncture wound effectively sealed itself by
the injected glue with no visible leakage. The procedure took
around 1 minute. Table 2 summarises the magnetic retraction
of a magnetised bowel segments in 20 ex vivo experiments
using both the 5mm and the 10mmmagnet probes.
The average pull force that surgeons use to provide suffi-
cient tension to the bowel is 2.5N [1] with the maximal force
being just below 5N. The test results obtained in the present
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Figure 4: (a)-(b) SEM images and (c) hysteresis curves completed at room temperature for two stainless steel microparticle of SS410-𝜇Ps (1)
and SS430-𝜇Ps (2).
study (Table 2) indicate that SS410-𝜇Ps based bowel magne-
tization is capable of providing retraction forces and work in
this range with use of 5 and 10mmdiameter permanent mag-
net probes. One important advantage of magnetic retraction
over conventional pull traction by teeth-like graspers is that
it inflicts less stress during high tension retraction with the
tissues being not only retracted but compressed between the
ridges of the graspers. For example, average pressures at the
tip of conventional graspers at the contact surface area with
the target tissue vary from210 kPa to 650 kPa [25]. In contrast,
the current approach does not require such compression and
much lower pressures (65 kPa to 114 kPa) were observed in
the current experiments by the 10mm and 5mm diameter
magnetic probes, respectively (Table 2).
3.4. On-Going Iron Oxide Nanoparticles Formulations. Mag-
netic nanoparticles can potentially exhibit stronger magnetic
properties than microparticles per unit mass. This arises
because bulkmagnetic materials present multiple domains of
magnetisations. Within each domain, the magnetisation has
only one direction, which however can vary fromone domain
to another. The presence of several interacting domains in
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one particle with potentially different orientations can result
in lowering the overall magnetisation of the particle. In
contrast, decrease of the size of the particles to a single
domain excludes the possibility of magnetic interactions
between multiple magnetic domains within a single particle.
If the nanoparticles do not carry a magnetic “dead-layer” at
their interface, their magnetic properties can be enhanced
compared to microparticles when exposed to the same
magnetic field [26–28].
Magnetic nanoparticles have been successfully used for
numerous biomedical applications [29–34]; however we
found that iron oxide nPs could not be mixed easily with
Loctite 4014 liquid for medical magnetic glue injection. For
this reason the on-going studies by the group is exploring
ways to overcome this problem as it is related to the fast
polymerization of the glue when mixed with the iron oxide
nanoparticles. This is likely associated with the surface
reactivity of the nanoparticles which needs to be adequately
tuned and possibly coated to enable development of efficient
nanoparticle-based medical magneto-glues.
4. Discussion
Thenew system based on formation of intraluminalmagnetic
coagulum provides highly effective atraumatic retraction and
overcomes the problems reported with previous approaches
based on localised ferromagnetisation of tissues, that is,
low injection volume during interstitial ferromagnetisation
[8] and peeling of surface magnetic pellets beyond certain
retraction forces [7]. Furthermore, it provides significantly
greater retraction forces, which meet all the requirements
for uncompromised bowel retraction/manipulation during
MAS equivalent to bowel grasping without risk of trauma or
slippage. Additionally, the results of the present experiments
have excluded thermal injury to the issues induced bymedical
grade cyanoacrylate glues during polymerisation. Loctite
4014 glue was selected because of its very low viscosity, single
component nature, rapid cure rate, and ability to mix with
stainless steel microparticles.
To date, ex vivo porcine bowel segments have been used
to validate the concept and measure the forces generated
(Figure 5). To facilitate intraluminal injection at randomly
selected target bowel segment, an open abdominal model
was used instead of a laparoscopic model. Two mL magnetic
gluewas injected intraluminally into targeted bowel segments
and the 10mm diameter magnet probe used to retract the
magnetised bowel (Figure 5(a)) which could be manipulated
andmoved around, and retracted (Figure 5(b)) withmaximal
pull detachment force of 5N, which was in agreement with
Instron bench test results using ex vivo bowel segments
(Table 2).
The ex vivo experiments with the formulated magnetic
glue also demonstrated that even small volumes (2mL)
injected intraluminally in target bowel segments enable
effective magnetic bowel retraction using a small (5 to 10mm
diameter) permanentmagnet probes. For the same retraction
force, the experimental data confirmed that the stress exerted
on the target tissue by magnetic probes was significantly less
when compared with the force generated during retraction
(a)
(b)
Figure 5: Retraction of in situ magnetised bowel using an ex
vivo porcine model and a volume of 2mL magnetic media with
concentration of 1 g/mL was injected into a bowel segment: (a)
photography showing the 10mm magnet probe inserted into a
10mm port and engaged with the magnetised bowel segment; (b)
photography showing retraction of themagnetised bowel toward the
port direction, with maximal detachment force of 5N.
by grasping forceps (65 kPa versus 210 kPa). Furthermore,
the magnetic probe does not gather the tissue into a fold but
instead creates a flat and smooth contact area with a wider
distribution of probe-tissue contact forces. This underlies
the atraumatic nature of magnetic retraction since the tissue
falls off when the force exceeds the magnetic pull. Active
release of the magnetically retracted tissue can be obtained
by custom-designed probes which adjust the magnetic
attraction force through a controlled release mechanism.
Our experiments also confirmed that change of retrac-
tion speed (from 0.1mm/s to 10mm/s) does not affect the
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magnetic retraction force and work, suggesting that bowel
retractedwith such probeswould not have to bemoved slowly
during surgery. The experiments demonstrate that compared
to external (serosal) application, the intraluminal magnetic
coagulum significantly increases themaximal retraction force
(1.75 ± 0.86N versus 5.15 ± 0.98N) with the use of a 10mm
magnet probe. Once the external magnet probe is removed,
the coagulum detaches from the mucosa and thus becomes
susceptible to spontaneous elimination in the stools. An
adjustable magnetic force probe is desirable for controlled
release of tissue whenever this is required. A simple and
effective design for such a probe has been designed and
developed in our lab and will be published elsewhere.
5. Conclusions
The results of the current experimental study confirm that,
with the technology described, intraluminal magnetic coag-
ula formed from medical-grade biocompatible cyanoacry-
late (Loctite) and SS410-𝜇Ps constitutes a novel system for
efficient and atraumatic magnetic retraction of bowel. The
system provides the retraction forces required for bowel
manipulation and handling during laparoscopic surgery. The
technology functions by producing a coagulum containing
a sufficient mass of aggregated stainless steel microparticles
adherent to the mucosa. This is either removed with the
specimen in resectional bowel surgery or is expelled with
return of bowel function. Further improvement is foreseen
with the use of polymer coated nanoparticles of iron oxide
being developed in our laboratory instead of stainless steel
microparticles. Evaluation of the fully developed technology
by in vivo large animal studies before translation to clinical
practice is needed.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Acknowledgment
Thisworkwas supported by the Engineering andPhysical Sci-
ences Research Council (EPSRC), UK, under Grant EP/HO
10033/1.
References
[1] E. A. M. Heijnsdijk, H. de Visser, J. Dankelman, and D. J.
Gouma, “Slip and damage properties of jaws of laparoscopic
graspers,” Surgical Endoscopy and Other Interventional Tech-
niques, vol. 18, no. 6, pp. 974–979, 2004.
[2] E. A. M. Heijnsdijk, J. Dankelman, and D. J. Gouma, “Effec-
tiveness of grasping and duration of clamping using laparo-
scopic graspers,” Surgical Endoscopy and Other Interventional
Techniques, vol. 16, no. 9, pp. 1329–1331, 2002.
[3] P.-O. Park, M. Bergstro¨m, K. Ikeda, A. Fritscher-Ravens, and
P. Swain, “Experimental studies of transgastric gallbladder
surgery: cholecystectomy and cholecystogastric anastomosis
(videos),”Gastrointestinal Endoscopy, vol. 61, no. 4, pp. 601–606,
2005.
[4] M. Ryou and C. C.Thompson, “Magnetic retraction in natural-
orifice transluminal endoscopic surgery (NOTES): addressing
the problem of traction and countertraction,” Endoscopy, vol.
41, no. 2, pp. 143–148, 2009.
[5] Q. A. Pankhurst, J. Connolly, S. K. Jones, and J. Dobson, “Appli-
cations of magnetic nanoparticles in biomedicine,” Journal of
Physics D, vol. 36, no. 13, pp. R167–R181, 2003.
[6] R. A. Frimpong and J. Z. Hilt, “Magnetic nanoparticles in
biomedicine: synthesis, functionalization and applications,”
Nanomedicine, vol. 5, no. 9, pp. 1401–1414, 2010.
[7] Z.Wang, L.Wang, B. Tang, T. Frank, S. Brown, andA.Cuschieri,
“Retraction by surface ferromagnetisation of target tissues:
preliminary studies on feasibility of magnetic retraction for
endoscopic surgery,” Surgical Endoscopy and Other Interven-
tional Techniques, vol. 22, no. 8, pp. 1838–1844, 2008.
[8] Z. Wang, L. Wang, S. I. Brown, T. G. Frank, and A. Cuschieri,
“Ferromagnetization of target tissues by interstitial injection of
ferrofluid: formulation and evidence of efficacy for magnetic
retraction,” IEEE Transactions on Biomedical Engineering, vol.
56, no. 9, pp. 2244–2252, 2009.
[9] G. G. M. Pinkse, E. Steenvoorde, S. Hogendoorn et al., “Stable
transplantation results of magnetically retracted islets: a novel
method,” Diabetologia, vol. 47, no. 1, pp. 55–61, 2004.
[10] D. C. Meeker, E. H. Maslen, R. C. Ritter, and F. M. Creighton,
“Optimal realization of arbitrary forces in amagnetic stereotaxis
system,” IEEE Transactions onMagnetics, vol. 32, no. 2, pp. 320–
328, 1996.
[11] S. Martel, J.-B. Mathieu, O. Felfoul et al., “Automatic navigation
of an untethered device in the artery of a living animal using
a conventional clinical magnetic resonance imaging system,”
Applied Physics Letters, vol. 90, no. 11, Article ID 114105, 2007.
[12] J. Cadeddu, R. Fernandez, M. Desai et al., “Novel magneti-
cally guided intra-abdominal camera to facilitate laparoendo-
scopic single-site surgery: initial human experience,” Surgical
Endoscopy and Other Interventional Techniques, vol. 23, no. 8,
pp. 1894–1899, 2009.
[13] M. T. Gettman and P. Swain, “Initial experimental evaluation
of wireless capsule endoscopes in the bladder: implications for
capsule cystoscopy,” European Urology, vol. 55, no. 5, pp. 1207–
1212, 2009.
[14] T. Uchiyama, K. Mohri, M. Shinkai et al., “Position sensing of
magnetite gel using MI sensor for brain tumor detection,” IEEE
Transactions on Magnetics, vol. 33, no. 5, pp. 4266–4268, 1997.
[15] J. M. Peeters, J.-H. Seppenwoolde, L. W. Bartels, and C. J. G.
Bakker, “Development and testing of passive tracking markers
for different field strengths and tracking speeds,” Physics in
Medicine and Biology, vol. 51, no. 6, pp. N127–N137, 2006.
[16] T. Ohdaira and H. Nagai, “Intraoperative localization of early-
stage upper gastrointestinal tumors using a magnetic marking
clip-detecting system,” Surgical Endoscopy and other Interven-
tional Techniques, vol. 21, no. 5, pp. 810–815, 2007.
[17] D. Erdmann, R. Sweis, C. Heitmann et al., “Side-to-side suture-
less vascular anastomosis with magnets,” Journal of Vascular
Surgery, vol. 40, no. 3, pp. 505–511, 2004.
[18] N. Muraoka, H. Uematsu, E. Yamanouchi et al., “Yamanouchi
magnetic compression anastomosis for bilioenteric anastomotic
stricture after living-donor liver transplantation,” Journal of
Vascular and Interventional Radiology, vol. 16, no. 9, pp. 1263–
1267, 2005.
8 BioMed Research International
[19] A. J. Singer, T. Zimmerman, J. Rooney, P. Cameau, G. Rudomen,
and S. A. McClain, “Comparison of wound-bursting strengths
and surface characteristics of FDA-approved tissue adhesives
for skin closure,” Journal of Adhesion Science and Technology,
vol. 18, no. 1, pp. 19–27, 2004.
[20] M. A. Astrahan, M. D. Sapozink, D. Cohen et al., “Microwave
applicator for transurethral hyperthermia of benign prostatic
hyperplasia,” International Journal of Hyperthermia, vol. 5, no.
3, pp. 283–296, 1989.
[21] H. Chen, M. D. Kaminski, A. D. Ebner, J. A. Ritter, and A. J.
Rosengart, “Magnetizable intravascular stents for sequestration
of systemically circulating magnetic nano- and microspheres,”
in Proceedings of the 3rd IEEE/EMBS Special Topic Conference
on Microtechnology in Medicine and Biology, pp. 286–289, May
2005.
[22] H. Chen, A. D. Ebner, D. Bockenfeld et al., “A comprehensive in
vitro investigation of a portable magnetic separator device for
human blood detoxification,” Physics in Medicine and Biology,
vol. 52, no. 19, pp. 6053–6072, 2007.
[23] C. Eouani, P. Piccerelle, P. Prinderre, E. Bourret, and J.
Joachim, “In-vitro comparative study of buccal mucoadhesive
performance of different polymeric films,” European Journal of
Pharmaceutics and Biopharmaceutics, vol. 52, no. 1, pp. 45–55,
2001.
[24] Pharmacokinetics, Marcel Dekker, New York, NY, USA, 1982,
edited by M. Gibaldi and M. Perrier.
[25] J. A. Cartmill, A. J. Shakeshaft, W. R. Walsht, and C. J. Martin,
“High pressures are generated at the tip of laparoscopic grasp-
ers,” Australian and New Zealand Journal of Surgery, vol. 69, no.
2, pp. 127–130, 1999.
[26] M. Mikhaylova, D. K. Kim, N. Bobrysheva et al., “Superpara-
magnetism of magnetite nanoparticles: dependence on surface
modification,” Langmuir, vol. 20, no. 6, pp. 2472–2477, 2004.
[27] C. d. Montferrand, Y. Lalatonne, D. Bonnin et al., “Size-
dependent nonlinear weak-field magnetic behavior of
maghemite nanoparticles,” Small, vol. 8, no. 12, pp. 1945–
1956, 2012.
[28] U. Jeong, X. Teng, Y. Wang, H. Yang, and Y. Xia, “Superpara-
magnetic colloids: controlled synthesis and niche applications,”
Advanced Materials, vol. 19, no. 1, pp. 33–60, 2007.
[29] G. A. O. Jinhao, G. U. Hongwei, and X. U. Bing, “Multifunc-
tional magnetic nanoparticles: design, synthesis, and biomedi-
cal applications,” Accounts of Chemical Research, vol. 42, no. 8,
pp. 1097–1107, 2009.
[30] M. Oudkerk, A. G. van den Heuvel, P. A. Wielopolski, P. I.
M. Schmitz, I. H. M. Borel Rinkes, and T. Wiggers, “Hepatic
lesions: detection with ferumoxide-enhanced T1-weighted MR
imaging,” Radiology, vol. 203, no. 2, pp. 449–456, 1997.
[31] R. C. Semelka andT. K.G.Helmberger, “State of the art: contrast
agents for mr imaging of the liver,” Radiology, vol. 218, no. 1, pp.
27–38, 2001.
[32] S. Chen, C. Hoskins, L. Wang, M. P. MacDonald, and P. Andre´,
“A water-soluble temperature nanoprobe based on a multi-
modal magnetic-luminescent nanocolloid,” Chemical Commu-
nications, vol. 48, no. 19, pp. 2501–2503, 2012.
[33] S. Chen, L. Wang, S. L. Duce et al., “Engineered biocompatible
nanoparticles for in vivo imaging applications,” Journal of the
American Chemical Society, vol. 132, no. 42, pp. 15022–15029,
2010.
[34] L. Motte, F. Benyettou, C. de Beaucorps, M. Lecouvey, I.
Milesovic, and Y. Lalatonne, “Multimodal superparamagnetic
nanoplatform for clinical applications: immunoassays, imaging
& therapy,” Faraday Discussions, vol. 149, pp. 211–225, 2011.
Submit your manuscripts at
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Anatomy 
Research International
Peptides
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation 
http://www.hindawi.com
 International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Molecular Biology 
International 
Hindawi Publishing Corporation
http://www.hindawi.com
Genomics
International Journal of
Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Bioinformatics
Advances in
Marine Biology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Signal Transduction
Journal of
BioMed Research 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Evolutionary Biology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Biochemistry 
Research International
Archaea
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Genetics 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporation
http://www.hindawi.com
Nucleic Acids
Journal of
Volume 2014
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Enzyme 
Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Microbiology
